ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Scopolamine Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-4Y2681
Home | Market Reports
Global Scopolamine Market Insights Forecast to 2026
BUY CHAPTERS

Global Scopolamine Market Research Report 2026

Code: QYRE-Auto-4Y2681
Report
2026-02-05
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin

Scopolamine Market Size

The global Scopolamine market was valued at US$ 12.39 million in 2025 and is anticipated to reach US$ 16.45 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Scopolamine Market

Scopolamine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Scopolamine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
This report delivers a comprehensive overview of the global Scopolamine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Scopolamine. The Scopolamine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Scopolamine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Scopolamine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Scopolamine Market Report

Report Metric Details
Report Name Scopolamine Market
Accounted market size in 2025 US$ 12.39 million
Forecasted market size in 2032 US$ 16.45 million
CAGR 4.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Scopolamine Butylbromide
  • Scopolamine Hydrobromide
  • Others
by Application
  • Tablets
  • Injection
  • Patches
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Scopolamine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Scopolamine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Scopolamine Market growing?

Ans: The Scopolamine Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Scopolamine Market size in 2032?

Ans: The Scopolamine Market size in 2032 will be US$ 16.45 million.

What is the market share of major companies in Scopolamine Market?

Ans: The top 3 players occupy about 55% shares of the global market.

What is the Scopolamine Market share by type?

Ans: Scopolamine Hydrobromide is the main type, with a share about 45%.

What is the Scopolamine Market share by application?

Ans: Patches is the main application, which holds a share about 60%.

Who are the main players in the Scopolamine Market report?

Ans: The main players in the Scopolamine Market are Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin

What are the Application segmentation covered in the Scopolamine Market report?

Ans: The Applications covered in the Scopolamine Market report are Tablets, Injection, Patches

What are the Type segmentation covered in the Scopolamine Market report?

Ans: The Types covered in the Scopolamine Market report are Scopolamine Butylbromide, Scopolamine Hydrobromide, Others

1 Scopolamine Market Overview
1.1 Product Definition
1.2 Scopolamine by Type
1.2.1 Global Scopolamine Market Value by Type: 2025 vs 2032
1.2.2 Scopolamine Butylbromide
1.2.3 Scopolamine Hydrobromide
1.2.4 Others
1.3 Scopolamine by Application
1.3.1 Global Scopolamine Market Value by Application: 2025 vs 2032
1.3.2 Tablets
1.3.3 Injection
1.3.4 Patches
1.4 Global Scopolamine Market Size Estimates and Forecasts
1.4.1 Global Scopolamine Revenue 2021–2032
1.4.2 Global Scopolamine Sales 2021–2032
1.4.3 Global Scopolamine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Scopolamine Market Competition by Manufacturers
2.1 Global Scopolamine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Scopolamine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Scopolamine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Scopolamine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Scopolamine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Scopolamine, Product Types and Applications
2.7 Global Key Manufacturers of Scopolamine, Date of Entry into the Industry
2.8 Global Scopolamine Market Competitive Situation and Trends
2.8.1 Global Scopolamine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Scopolamine Players Market Share by Revenue
2.8.3 Global Scopolamine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Scopolamine Market Scenario by Region
3.1 Global Scopolamine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Scopolamine Sales by Region: 2021–2032
3.2.1 Global Scopolamine Sales by Region: 2021–2026
3.2.2 Global Scopolamine Sales by Region: 2027–2032
3.3 Global Scopolamine Revenue by Region: 2021–2032
3.3.1 Global Scopolamine Revenue by Region: 2021–2026
3.3.2 Global Scopolamine Revenue by Region: 2027–2032
3.4 North America Scopolamine Market Facts & Figures by Country
3.4.1 North America Scopolamine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Scopolamine Sales by Country (2021–2032)
3.4.3 North America Scopolamine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Scopolamine Market Facts & Figures by Country
3.5.1 Europe Scopolamine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Scopolamine Sales by Country (2021–2032)
3.5.3 Europe Scopolamine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Scopolamine Market Facts & Figures by Region
3.6.1 Asia Pacific Scopolamine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Scopolamine Sales by Region (2021–2032)
3.6.3 Asia Pacific Scopolamine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Scopolamine Market Facts & Figures by Country
3.7.1 Latin America Scopolamine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Scopolamine Sales by Country (2021–2032)
3.7.3 Latin America Scopolamine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Scopolamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Scopolamine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Scopolamine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Scopolamine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Scopolamine Sales by Type (2021–2032)
4.1.1 Global Scopolamine Sales by Type (2021–2026)
4.1.2 Global Scopolamine Sales by Type (2027–2032)
4.1.3 Global Scopolamine Sales Market Share by Type (2021–2032)
4.2 Global Scopolamine Revenue by Type (2021–2032)
4.2.1 Global Scopolamine Revenue by Type (2021–2026)
4.2.2 Global Scopolamine Revenue by Type (2027–2032)
4.2.3 Global Scopolamine Revenue Market Share by Type (2021–2032)
4.3 Global Scopolamine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Scopolamine Sales by Application (2021–2032)
5.1.1 Global Scopolamine Sales by Application (2021–2026)
5.1.2 Global Scopolamine Sales by Application (2027–2032)
5.1.3 Global Scopolamine Sales Market Share by Application (2021–2032)
5.2 Global Scopolamine Revenue by Application (2021–2032)
5.2.1 Global Scopolamine Revenue by Application (2021–2026)
5.2.2 Global Scopolamine Revenue by Application (2027–2032)
5.2.3 Global Scopolamine Revenue Market Share by Application (2021–2032)
5.3 Global Scopolamine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Alkaloids of Australia
6.1.1 Alkaloids of Australia Company Information
6.1.2 Alkaloids of Australia Description and Business Overview
6.1.3 Alkaloids of Australia Scopolamine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Alkaloids of Australia Scopolamine Product Portfolio
6.1.5 Alkaloids of Australia Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Scopolamine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Scopolamine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Fine Chemicals Corporation
6.3.1 Fine Chemicals Corporation Company Information
6.3.2 Fine Chemicals Corporation Description and Business Overview
6.3.3 Fine Chemicals Corporation Scopolamine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Fine Chemicals Corporation Scopolamine Product Portfolio
6.3.5 Fine Chemicals Corporation Recent Developments/Updates
6.4 Phytex Australia
6.4.1 Phytex Australia Company Information
6.4.2 Phytex Australia Description and Business Overview
6.4.3 Phytex Australia Scopolamine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Phytex Australia Scopolamine Product Portfolio
6.4.5 Phytex Australia Recent Developments/Updates
6.5 Alchem International
6.5.1 Alchem International Company Information
6.5.2 Alchem International Description and Business Overview
6.5.3 Alchem International Scopolamine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Alchem International Scopolamine Product Portfolio
6.5.5 Alchem International Recent Developments/Updates
6.6 Guangzhou Hanfang
6.6.1 Guangzhou Hanfang Company Information
6.6.2 Guangzhou Hanfang Description and Business Overview
6.6.3 Guangzhou Hanfang Scopolamine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Guangzhou Hanfang Scopolamine Product Portfolio
6.6.5 Guangzhou Hanfang Recent Developments/Updates
6.7 Alkaloids Corporation
6.7.1 Alkaloids Corporation Company Information
6.7.2 Alkaloids Corporation Description and Business Overview
6.7.3 Alkaloids Corporation Scopolamine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Alkaloids Corporation Scopolamine Product Portfolio
6.7.5 Alkaloids Corporation Recent Developments/Updates
6.8 Luyin
6.8.1 Luyin Company Information
6.8.2 Luyin Description and Business Overview
6.8.3 Luyin Scopolamine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Luyin Scopolamine Product Portfolio
6.8.5 Luyin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Scopolamine Industry Chain Analysis
7.2 Scopolamine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Scopolamine Production Mode & Process Analysis
7.4 Scopolamine Sales and Marketing
7.4.1 Scopolamine Sales Channels
7.4.2 Scopolamine Distributors
7.5 Scopolamine Customer Analysis
8 Scopolamine Market Dynamics
8.1 Scopolamine Industry Trends
8.2 Scopolamine Market Drivers
8.3 Scopolamine Market Challenges
8.4 Scopolamine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
List of Tables
 Table 1. Global Scopolamine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Scopolamine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Scopolamine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Scopolamine Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Scopolamine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Scopolamine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Scopolamine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Scopolamine Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Scopolamine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Scopolamine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Scopolamine, Product Types and Applications
 Table 12. Global Key Manufacturers of Scopolamine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Scopolamine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Scopolamine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Scopolamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Scopolamine Sales by Region (K Units), 2021–2026
 Table 18. Global Scopolamine Sales Market Share by Region (2021–2026)
 Table 19. Global Scopolamine Sales by Region (K Units), 2027–2032
 Table 20. Global Scopolamine Sales Market Share by Region (2027–2032)
 Table 21. Global Scopolamine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Scopolamine Revenue Market Share by Region (2021–2026)
 Table 23. Global Scopolamine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Scopolamine Revenue Market Share by Region (2027–2032)
 Table 25. North America Scopolamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Scopolamine Sales by Country (K Units), 2021–2026
 Table 27. North America Scopolamine Sales by Country (K Units), 2027–2032
 Table 28. North America Scopolamine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Scopolamine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Scopolamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Scopolamine Sales by Country (K Units), 2021–2026
 Table 32. Europe Scopolamine Sales by Country (K Units), 2027–2032
 Table 33. Europe Scopolamine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Scopolamine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Scopolamine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Scopolamine Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Scopolamine Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Scopolamine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Scopolamine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Scopolamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Scopolamine Sales by Country (K Units), 2021–2026
 Table 42. Latin America Scopolamine Sales by Country (K Units), 2027–2032
 Table 43. Latin America Scopolamine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Scopolamine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Scopolamine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Scopolamine Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Scopolamine Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Scopolamine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Scopolamine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Scopolamine Sales (K Units) by Type (2021–2026)
 Table 51. Global Scopolamine Sales (K Units) by Type (2027–2032)
 Table 52. Global Scopolamine Sales Market Share by Type (2021–2026)
 Table 53. Global Scopolamine Sales Market Share by Type (2027–2032)
 Table 54. Global Scopolamine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Scopolamine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Scopolamine Revenue Market Share by Type (2021–2026)
 Table 57. Global Scopolamine Revenue Market Share by Type (2027–2032)
 Table 58. Global Scopolamine Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Scopolamine Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Scopolamine Sales (K Units) by Application (2021–2026)
 Table 61. Global Scopolamine Sales (K Units) by Application (2027–2032)
 Table 62. Global Scopolamine Sales Market Share by Application (2021–2026)
 Table 63. Global Scopolamine Sales Market Share by Application (2027–2032)
 Table 64. Global Scopolamine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Scopolamine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Scopolamine Revenue Market Share by Application (2021–2026)
 Table 67. Global Scopolamine Revenue Market Share by Application (2027–2032)
 Table 68. Global Scopolamine Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Scopolamine Price (USD/Unit) by Application (2027–2032)
 Table 70. Alkaloids of Australia Company Information
 Table 71. Alkaloids of Australia Description and Business Overview
 Table 72. Alkaloids of Australia Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Alkaloids of Australia Scopolamine Product
 Table 74. Alkaloids of Australia Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Boehringer Ingelheim Scopolamine Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. Fine Chemicals Corporation Company Information
 Table 81. Fine Chemicals Corporation Description and Business Overview
 Table 82. Fine Chemicals Corporation Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Fine Chemicals Corporation Scopolamine Product
 Table 84. Fine Chemicals Corporation Recent Developments/Updates
 Table 85. Phytex Australia Company Information
 Table 86. Phytex Australia Description and Business Overview
 Table 87. Phytex Australia Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Phytex Australia Scopolamine Product
 Table 89. Phytex Australia Recent Developments/Updates
 Table 90. Alchem International Company Information
 Table 91. Alchem International Description and Business Overview
 Table 92. Alchem International Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Alchem International Scopolamine Product
 Table 94. Alchem International Recent Developments/Updates
 Table 95. Guangzhou Hanfang Company Information
 Table 96. Guangzhou Hanfang Description and Business Overview
 Table 97. Guangzhou Hanfang Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Guangzhou Hanfang Scopolamine Product
 Table 99. Guangzhou Hanfang Recent Developments/Updates
 Table 100. Alkaloids Corporation Company Information
 Table 101. Alkaloids Corporation Description and Business Overview
 Table 102. Alkaloids Corporation Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Alkaloids Corporation Scopolamine Product
 Table 104. Alkaloids Corporation Recent Developments/Updates
 Table 105. Luyin Company Information
 Table 106. Luyin Description and Business Overview
 Table 107. Luyin Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Luyin Scopolamine Product
 Table 109. Luyin Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Scopolamine Distributors List
 Table 113. Scopolamine Customers List
 Table 114. Scopolamine Market Trends
 Table 115. Scopolamine Market Drivers
 Table 116. Scopolamine Market Challenges
 Table 117. Scopolamine Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Scopolamine
 Figure 2. Global Scopolamine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Scopolamine Market Share by Type: 2025 & 2032
 Figure 4. Scopolamine Butylbromide Product Picture
 Figure 5. Scopolamine Hydrobromide Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Scopolamine Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Scopolamine Market Share by Application: 2025 & 2032
 Figure 9. Tablets
 Figure 10. Injection
 Figure 11. Patches
 Figure 12. Global Scopolamine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Scopolamine Market Size (US$ Million), 2021–2032
 Figure 14. Global Scopolamine Sales (K Units), 2021–2032
 Figure 15. Global Scopolamine Average Price (USD/Unit), 2021–2032
 Figure 16. Scopolamine Report Years Considered
 Figure 17. Scopolamine Sales Share by Manufacturers in 2025
 Figure 18. Global Scopolamine Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Scopolamine Players: Market Share by Revenue in Scopolamine in 2025
 Figure 20. Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Scopolamine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Scopolamine Sales Market Share by Country (2021–2032)
 Figure 23. North America Scopolamine Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Scopolamine Sales Market Share by Country (2021–2032)
 Figure 27. Europe Scopolamine Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Scopolamine Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Scopolamine Revenue Market Share by Region (2021–2032)
 Figure 35. China Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Scopolamine Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Scopolamine Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Scopolamine Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Scopolamine Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Scopolamine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Scopolamine by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Scopolamine by Type (2021–2032)
 Figure 56. Global Scopolamine Price (USD/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Scopolamine by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Scopolamine by Application (2021–2032)
 Figure 59. Global Scopolamine Price (USD/Unit) by Application (2021–2032)
 Figure 60. Scopolamine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Hyoscine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Scopolamine Transdermal Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Scopolamine Butylbromide Capsules Market Research Report 2024
Global Anticholinergic Travel Sickness Drugs Market Insights Forecast to 2030
Global Scopolamine Butylbromide for Injection Market Research Report 2024
Global Nausea And Vomiting Treatment Market Insights Forecast to 2030
Global Scopolamine Butylbromide Injection Market Research Report 2025
Cyclizine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ephedrine Market Insights Forecast to 2030
Global Atropine Market Insights Forecast to 2030
Anticholinergic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atropine Medication Market Research Report 2024
Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metoclopramide Market Research Report 2024
Global Esketamine Market Insights Forecast to 2030
Global Antihistamines Travel Sickness Drugs Market Insights Forecast to 2030
Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Research Report 2024
Global Propacetamol Market Research Report 2024
Postoperative Nausea and Vomiting Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Electronic Antiemetic Device Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions